{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:39:31Z","timestamp":1790937571686,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002864","name":"Chonbuk National University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["2010-0001730"],"award-info":[{"award-number":["2010-0001730"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.cllc.2011.02.006","type":"journal-article","created":{"date-parts":[[2011,5,24]],"date-time":"2011-05-24T04:18:30Z","timestamp":1306210710000},"page":"380-386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["EGFR Mutation Status in Primary Lung Adenocarcinomas and Corresponding Metastatic Lesions: Discordance in Pleural Metastases"],"prefix":"10.1016","volume":"12","author":[{"given":"Hye-Suk","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Woon","family":"Eom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Heon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyang-Mi","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Young","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Man","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang Hyeon","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Hyeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Taik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hae","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-chang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ok-Jun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2011.02.006_bib1","series-title":"GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide","author":"Ferlay","year":"2004"},{"key":"10.1016\/j.cllc.2011.02.006_bib2","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cllc.2011.02.006_bib3","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(05)67625-8","article-title":"Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)","volume":"366","author":"Thatcher","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cllc.2011.02.006_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa050753","article-title":"Erlotinib in previously treated non-small-cell lung cancer","volume":"353","author":"Shepherd","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cllc.2011.02.006_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1056\/NEJMoa050736","article-title":"Erlotinib in lung cancer - molecular and clinical predictors of outcome","volume":"353","author":"Tsao","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cllc.2011.02.006_bib6","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0140-6736(08)61758-4","article-title":"Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial","volume":"372","author":"Kim","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.cllc.2011.02.006_bib7","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma","volume":"361","author":"Mok","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cllc.2011.02.006_bib8","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1056\/NEJMoa0909530","article-title":"Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR","volume":"362","author":"Maemondo","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cllc.2011.02.006_bib9","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1158\/1078-0432.CCR-06-3043","article-title":"KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer","volume":"13","author":"Massarelli","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2011.02.006_bib10","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/JTO.0b013e3181e2f4d6","article-title":"Prognostic implications of epidermal growth factor receptor and KRAS gene mutations and epidermal growth factor receptor gene copy numbers in patients with surgically resectable non-small cell lung cancer in Taiwan","volume":"5","author":"Liu","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.cllc.2011.02.006_bib11","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.lungcan.2009.11.020","article-title":"KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: a meta-analysis of 22 studies","volume":"69","author":"Mao","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2011.02.006_bib12","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1200\/JCO.2005.02.857","article-title":"Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib","volume":"23","author":"Eberhard","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2011.02.006_bib13","doi-asserted-by":"crossref","first-page":"8919","DOI":"10.1158\/0008-5472.CAN-04-2818","article-title":"Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications","volume":"64","author":"Kosaka","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2011.02.006_bib14","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1200\/JCO.2005.08.043","article-title":"EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment","volume":"23","author":"Marchetti","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2011.02.006_bib15","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1158\/1078-0432.CCR-05-1981","article-title":"Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features","volume":"12","author":"Tam","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2011.02.006_bib16","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1183\/09031936.01.00225601","article-title":"Management of malignant pleural effusions","volume":"18","author":"Antony","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cllc.2011.02.006_bib17","series-title":"AJCC Cancer Staging Manual","author":"Edge","year":"2010"},{"key":"10.1016\/j.cllc.2011.02.006_bib18","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/ijc.21940","article-title":"Frequent EGFR mutations in brain metastases of lung adenocarcinoma","volume":"119","author":"Matsumoto","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cllc.2011.02.006_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF02893484","article-title":"Phenotype of bone metastases of non-small cell lung cancer: epidermal growth factor receptor expression and K-RAS mutational status","volume":"13","author":"Badalian","year":"2007","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.cllc.2011.02.006_bib20","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/sj.bjc.6604629","article-title":"Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC","volume":"99","author":"Kalikaki","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cllc.2011.02.006_bib21","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/annonc\/mdn679","article-title":"Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer","volume":"20","author":"Gow","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2011.02.006_bib22","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1158\/1078-0432.CCR-09-0089","article-title":"EGFR\/KRAS\/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases","volume":"15","author":"Schmid","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2011.02.006_bib23","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1158\/1078-0432.CCR-08-2921","article-title":"HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumors","volume":"15","author":"Sun","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2011.02.006_bib24","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/JTO.0b013e3181a94af4","article-title":"Discordance of molecular biomarkers associated with epidermal growth factor receptor pathway between primary tumors and lymph node metastasis in non-small cell lung cancer","volume":"4","author":"Park","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.cllc.2011.02.006_bib25","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1002\/cncr.25014","article-title":"KRAS mutation status in primary nonsmall cell lung cancer and matched metastases","volume":"116","author":"Cortot","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.cllc.2011.02.006_bib26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.humpath.2009.06.019","article-title":"A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases","volume":"41","author":"Monaco","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cllc.2011.02.006_bib27","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1126\/science.1164853","article-title":"Cancer","volume":"321","author":"Klein","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.cllc.2011.02.006_bib28","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrc2627","article-title":"Parallel progression of primary tumours and metastases","volume":"9","author":"Klein","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cllc.2011.02.006_bib29","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/418823a","article-title":"A progression puzzle","volume":"418","author":"Bernards","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cllc.2011.02.006_bib30","first-page":"2681","article-title":"Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage II non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value","volume":"62","author":"Sasatomi","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2011.02.006_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4161\/cc.3.1.634","article-title":"Gene expression sigantures, cancer cell evolution and metastatic progression","volume":"3","author":"Klein","year":"2004","journal-title":"Cell Cycle"},{"key":"10.1016\/j.cllc.2011.02.006_bib32","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0022-5223(96)70044-2","article-title":"Mode of spread in the early phase of lymphatic metastasis in non-small-cell lung cancer: significance of nodal micrometastasis","volume":"112","author":"Izbicki","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cllc.2011.02.006_bib33","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/415530a","article-title":"Gene expression profiling predicts clinical outcome of breast cancer","volume":"415","author":"van't Veer","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cllc.2011.02.006_bib34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S1535-6108(03)00167-3","article-title":"Evidence emerges for early metastasis and parallel evolution of primary and metastatic tumors","volume":"4","author":"Gray","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cllc.2011.02.006_bib35","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/sj.bjc.6603428","article-title":"EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib","volume":"95","author":"Kimura","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cllc.2011.02.006_bib36","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1002\/ijc.22190","article-title":"Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer","volume":"119","author":"Soh","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cllc.2011.02.006_bib37","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1183\/09031936.00167407","article-title":"Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma","volume":"32","author":"Wu","year":"2008","journal-title":"Eur Respir J"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730411000581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730411000581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:55:18Z","timestamp":1761504918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730411000581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1525730411000581"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2011.02.006","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EGFR Mutation Status in Primary Lung Adenocarcinomas and Corresponding Metastatic Lesions: Discordance in Pleural Metastases","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2011.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}